(in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
---|---|---|---|---|
Current assets | ||||
Cash | $242.56 | $156.51 | $157.49 | $186.64 |
Short term investments | $669.79 | $766.39 | $783.84 | $772.07 |
Net receivables | $83.9 | $88.3 | $91.14 | $98.56 |
Inventory | $38.15 | $36.81 | $33.02 | $31.72 |
Total current assets | $1034.41 | $1048 | $1065.49 | $1088.99 |
Long term investments | ||||
Property, plant & equipment | $97.7 | $85.94 | $78.95 | $74.2 |
Goodwill & intangible assets | ||||
Total noncurrent assets | $111.72 | $98.35 | $93.53 | $85.35 |
Total investments | $669.79 | $766.39 | $783.84 | $772.07 |
Total assets | $1146.13 | $1146.35 | $1159.02 | $1174.34 |
Current liabilities | ||||
Accounts payable | $94.39 | $79.67 | $82.54 | $81.47 |
Deferred revenue | $0.81 | $1.84 | ||
Short long term debt | ||||
Total current liabilities | $179.12 | $157.16 | $150.09 | $148.78 |
Long term debt | $596.24 | $590.04 | $587.48 | $586.3 |
Total noncurrent liabilities | $604.52 | $595.49 | $593.25 | $593.42 |
Total debt | $596.24 | $590.04 | $587.48 | $586.3 |
Total liabilities | $783.63 | $752.65 | $743.33 | $742.19 |
Shareholders' equity | ||||
Retained earnings | -$985.5 | -$938.42 | -$888.94 | -$831.52 |
Other shareholder equity | -$5.47 | -$1.99 | -$1.98 | -$2.69 |
Total shareholder equity | $362.5 | $393.7 | $415.68 | $432.15 |
(in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
---|---|---|---|---|
Current assets | ||||
Cash | $242.56 | $9.7 | $209.61 | $246.17 |
Short term investments | $669.79 | $854.1 | $728.9 | $607.9 |
Net receivables | $83.9 | $106.03 | $110.59 | $117.94 |
Inventory | $38.15 | $29.38 | $24.43 | $27.42 |
Total current assets | $1034.41 | $1111.53 | $1073.53 | $999.44 |
Long term investments | ||||
Property, plant & equipment | $97.7 | $68.96 | $53.88 | $41.63 |
Goodwill & intangible assets | ||||
Total noncurrent assets | $111.72 | $80.12 | $65.97 | $52.54 |
Total investments | $669.79 | $854.1 | $728.9 | $607.9 |
Total assets | $1146.13 | $1191.65 | $1139.49 | $1051.98 |
Current liabilities | ||||
Accounts payable | $94.39 | $85.2 | $72.6 | $113.61 |
Deferred revenue | $2.88 | $6.48 | $12.14 | |
Short long term debt | ||||
Total current liabilities | $179.12 | $158.78 | $142.6 | $113.61 |
Long term debt | $596.24 | $565.51 | $575.21 | $444.2 |
Total noncurrent liabilities | $604.52 | $591.7 | $586.4 | $461.85 |
Total debt | $596.24 | $584.27 | $575.21 | $444.2 |
Total liabilities | $783.63 | $750.48 | $729 | $575.46 |
Shareholders' equity | ||||
Retained earnings | -$985.5 | -$778.46 | -$685.93 | -$631.08 |
Other shareholder equity | -$5.47 | -$2.43 | -$3.17 | -$3.83 |
Total shareholder equity | $362.5 | $441.17 | $410.49 | $476.53 |
(in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $133.78 | $127.32 | $126.05 | $122.18 |
Cost of revenue | $32.56 | $32.09 | $34.02 | $29.61 |
Gross Profit | $101.23 | $95.23 | $92.03 | $92.57 |
Operating activities | ||||
Research & development | $54.31 | $53.62 | $55.43 | $59.7 |
Selling, general & administrative | $98.64 | $99.85 | $99.27 | $93.11 |
Total operating expenses | $152.94 | $153.47 | $154.69 | $152.82 |
Operating income | -$51.72 | -$58.24 | -$62.66 | -$60.25 |
Income from continuing operations | ||||
EBIT | -$51.72 | -$58.24 | -$62.66 | -$60.25 |
Income tax expense | $8.54 | $1.26 | $3.51 | $1.98 |
Interest expense | -$13.18 | -$10.02 | -$8.76 | -$9.17 |
Net income | ||||
Net income | -$47.08 | -$49.48 | -$57.42 | -$53.06 |
Income (for common shares) | -$47.08 | -$49.48 | -$57.42 | -$53.06 |
(in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $509.34 | $537.84 | $535.03 | $494.37 |
Cost of revenue | $128.28 | $114.87 | $114.88 | $106.5 |
Gross Profit | $381.06 | $422.97 | $420.15 | $387.87 |
Operating activities | ||||
Research & development | $223.06 | $206.09 | $201.3 | $132.01 |
Selling, general & administrative | $390.87 | $306.41 | $263.18 | $225.45 |
Total operating expenses | $613.93 | $512.5 | $464.49 | $357.46 |
Operating income | -$232.87 | -$89.52 | -$44.33 | $30.4 |
Income from continuing operations | ||||
EBIT | -$232.87 | -$89.52 | -$44.33 | $30.4 |
Income tax expense | $15.3 | $10.69 | $6.28 | -$1.71 |
Interest expense | -$41.13 | -$7.68 | $7.74 | $12.3 |
Net income | ||||
Net income | -$207.04 | -$92.53 | -$58.35 | $19.81 |
Income (for common shares) | -$207.04 | -$92.53 | -$58.35 | $19.81 |
(in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
---|---|---|---|---|
Net income | -$47.08 | -$49.48 | -$57.42 | -$53.06 |
Operating activities | ||||
Depreciation | $2.72 | $2.8 | $2.72 | $2.72 |
Business acquisitions & disposals | ||||
Stock-based compensation | $17.44 | $26.35 | $32.74 | $39.08 |
Total cash flows from operations | -$14.56 | -$19.31 | -$22.74 | -$16.73 |
Investing activities | ||||
Capital expenditures | -$6.82 | -$7.25 | -$6.93 | -$6.09 |
Investments | $105.32 | $24.51 | -$6.97 | $88.38 |
Total cash flows from investing | $98.5 | $17.26 | -$13.9 | $82.29 |
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | $1.53 | $2.88 | ||
Net borrowings | -$0 | -$0.01 | ||
Total cash flows from financing | $1.91 | $1.17 | $7.5 | $5.2 |
Effect of exchange rate | $0.2 | -$0.1 | -$0.01 | $0.04 |
Change in cash and equivalents | $86.05 | -$0.98 | -$29.14 | $70.81 |
(in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
---|---|---|---|---|
Net income | -$207.04 | -$92.53 | -$58.35 | $19.81 |
Operating activities | ||||
Depreciation | $10.97 | $10.62 | $10.25 | $9.15 |
Business acquisitions & disposals | ||||
Stock-based compensation | $115.61 | $106.95 | $94.9 | $75.72 |
Total cash flows from operations | -$73.34 | $30.79 | $82.76 | $99.15 |
Investing activities | ||||
Capital expenditures | -$27.09 | -$21.36 | -$24.17 | -$14.97 |
Investments | $211.24 | -$118.6 | -$120.66 | -$457.88 |
Total cash flows from investing | $184.15 | -$139.96 | -$144.83 | -$472.85 |
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | $4.42 | $5.22 | $4.55 | $3.37 |
Net borrowings | -$0.01 | -$0.03 | -$0.03 | $408.41 |
Total cash flows from financing | $15.79 | $15.49 | $25.7 | $440.21 |
Effect of exchange rate | $0.13 | -$0.1 | -$0.19 | $0.25 |
Change in cash and equivalents | $126.73 | -$93.78 | -$36.56 | $66.76 |
Is NovoCure Limited (NASDAQ:NVCR) Worth US$16.0 Based On Its Intrinsic Value?
Simply Wall St. via Yahoo Finance
29 Feb 2024
|
NovoCure Limited (NASDAQ:NVCR) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance
24 Feb 2024
|
The Top and Bottom Stocks of 2023
Investopedia
4 Dec 2023
|
NovoCure Limited (NASDAQ:NVCR) institutional owners may be pleased with recent gains after 85% loss...
Simply Wall St. via Yahoo Finance
16 Nov 2023
|
11 Best Undervalued UK Stocks To Buy Now
Insider Monkey via Yahoo Finance
14 Nov 2023
|
NovoCure (NASDAQ:NVCR investor three-year losses grow to 90% as the stock sheds US$229m this past...
Simply Wall St. via Yahoo Finance
8 Oct 2023
|
Should You Hold NovoCure Limited (NVCR)?
Insider Monkey via Yahoo Finance
18 Sep 2023
|
Why Novocure Stock Fell 24.4% This Week
Motley Fool
1 Sep 2023
|
HC Wainwright cuts NovoCure to neutral in wake of failed study (NVCR)
Seeking Alpha
29 Aug 2023
|
Why Is Novocure (NVCR) Stock Down 30% Today?
InvestorPlace
29 Aug 2023
|
Market cap | $1.67B |
---|---|
Enterprise value | $2.03B |
Shares outstanding | 107.08M |
Revenue | $509.34M |
---|---|
EBITDA | -$221.90M |
EBIT | -$232.87M |
Net Income | -$207.04M |
Revenue Q/Q | 4.17% |
Revenue Y/Y | -5.30% |
P/E ratio | -8.08 |
---|---|
EV/Sales | 3.98 |
EV/EBITDA | -9.14 |
EV/EBIT | -8.71 |
P/S ratio | 3.29 |
P/B ratio | 4.55 |
Book/Share | 3.44 |
Cash/Share | 2.27 |
EPS | -$1.93 |
---|---|
ROA | -17.90% |
ROE | -51.63% |
Debt/Equity | 2.16 |
---|---|
Net debt/EBITDA | -2.44 |
Current ratio | 5.78 |
Quick ratio | 5.56 |